➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Express Scripts
Merck
Dow
Harvard Business School

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Drug Price Trends for RILUZOLE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for RILUZOLE

Average Pharmacy Cost for RILUZOLE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
RILUZOLE 50 MG TABLET 68462-0381-60 1.20650 EACH 2020-07-22
RILUZOLE 50 MG TABLET 00378-4145-91 1.20650 EACH 2020-07-22
RILUZOLE 50 MG TABLET 60505-3285-06 1.20650 EACH 2020-07-22
RILUZOLE 50 MG TABLET 67877-0286-60 1.20650 EACH 2020-07-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for RILUZOLE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
TIGLUTIK 50MG/10ML SUSP,ORAL ITF Pharma 70726-0303-01 2X300ML 2357.26 2020-01-01 - 2024-08-14 Big4
TIGLUTIK 50MG/10ML SUSP,ORAL ITF Pharma 70726-0303-01 2X300ML 2792.26 2020-01-01 - 2024-08-14 FSS
TIGLUTIK 50MG/10ML SUSP,ORAL ITF Pharma 70726-0303-01 2X300ML 2357.91 2019-08-15 - 2024-08-14 Big4
TIGLUTIK 50MG/10ML SUSP,ORAL ITF Pharma 70726-0303-01 2X300ML 2849.25 2019-08-15 - 2024-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Merck
AstraZeneca
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.